TRACKABLE PILL

MA. DONNABELLE B. VARONA

XII- FLEMING
HISTORICAL BACKGROUND
 ABILIFY MYCITE

• A PILL THE RECORDS MEDICATION TO CHECK WHETHER OR

NOT IT WAS TAKEN BY THE PATIENT.
• APPROVED BY THE USA FDA IN NOVEMBER 15, 2002
 ABILIFY MYCITE

• THE PILL WAS USED TO TREAT SCHIZOPHRENIA AND BIPOLAR

DISORDERS.
• THE INGESTIBLE SENSOR WAS APPRIVED BY THE USA FDA IN
2012
• USA FDA APPROVED ABILIFY MYCITE TO OTSUKA
PHARMACEUTICAL CO., LTD. IN 2017
MAIN POINT OF THE DOCUMENT
 MAIN POINT OF THE DOCUMENT

• THE PILL HAS TWO MAIN COMPONENTS: THE PILL ITSELF THAT IS USED TO TREAT
SCHIZOPHRENIA, BIPOLAR DISORDERS, AND DEPRESSION IN ADULTS, AND THE TRACKING
SENSOR WHICH WAS APPROVED BY USA FDA IN 2012
• THE PILL HAS TRACKING SENSORS IN THEM SO THAT PATIENTS AND DOCTORS COULD CHECK
THEIR DOSAGE THROUGH THEIR SMARTPHONES AND ALSO TO BETTER CHECK IF TREATMENT
HAS BEEN ACTUALLY WORKING OR NOT.
 ANALYSIS

• THE MAIN POINT OF THE DOCUMENT WAS TO GIVE READERS NEW INFORMATION ABOUT THE PILL
AND HOW IT IS USED, AS WELL AS WHAT THEY USED IN ORDER FOR IT TO OPERATE.
• THE TEXT SHOWS HOW TO USE THE PILL, WHAT HAPPENS WHEN SOMEONE USES THE PILL, AND
THE POSSIBLE SIDE EFFECTS THE COULD BE REFLECTED IN A PATIENT ONCE THE PILL IS TAKEN.
• THE TEXT ALSO SHOWED THE MORAL AND ETHICAL DILEMMAS THAT SHOULD BE CONSIDERED
WHEN TAKING THE PILL. THOUGH THE PILL DEFINITELY HAD IT’S UPSIDES, SUCH AS PATIENTS NOT
HAVING TO BE CONFUSED WITH HOW MUCH SHOULD THEY TAKE AND WHAT SHOULD THEY TAKE,
THE SIDE EFECTS THAT SHOULD BE TAKEN INTO CONSIDERATION, AND THE APPROACH TO THE
PATIENTS THAT ARE TAKING SHOULD ALSO BE HELD IN HIGH REGARD.
THANK YOU VERY MUCH!!
 REFERENCES

• HTTPS://WWW.FDA.GOV/NEWSEVENTS/NEWSROOM/PRESSANNOUNCEMENTS/UCM58493
3.HTM
• HTTPS://WWW.ACCESSDATA.FDA.GOV/SCRIPTS/CDER/DAF/INDEX.CFM?EVENT=OVERVIEW.P
ROCESS&APPLNO=021436
• HTTP://WWW.DAILYMAIL.CO.UK/HEALTH/ARTICLE-5080427/U-S-APPROVES-DIGITAL-PILL-
TRACKS-PATIENTS-IT.HTML